Nisa Investment Advisors
VNDA icon

Nisa Investment Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History

Nisa Investment Advisors’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.09K Buy
341
+200
+142% +$1.31K ﹤0.01% 2747
2026
Q1 		$974 Hold
141
– – ﹤0.01% 2752
2025
Q4 		$1.24K Hold
141
– – ﹤0.01% 2687
2025
Q3 		$704 Hold
141
– – ﹤0.01% 2798
2025
Q2 		$666 Sell
141
-179
-56% -$783 ﹤0.01% 2822
2025
Q1 		$1.47K Sell
320
-11
-3% -$51 ﹤0.01% 2540
2024
Q4 		$1.58K Buy
331
+209
+171% +$1K ﹤0.01% 2562
2024
Q3 		$572 Sell
122
-110
-47% -$590 ﹤0.01% 2700
2024
Q2 		$1.31K Buy
+232
New +$1.2K ﹤0.01% 2456
2024
Q1 		– Sell
-30
Closed -$127 – 2820
2023
Q4 		$127 Buy
+30
New +$121 ﹤0.01% 2601
2023
Q3 		– Sell
-3,373
Closed -$22.2K – 2841
2023
Q2 		$22.2K Buy
3,373
+3,210
+1,969% +$20.6K ﹤0.01% 2061
2023
Q1 		$1K Buy
+163
New +$1.15K ﹤0.01% 2477
2022
Q2 		– Sell
-8,540
Closed -$97K – 2516
2022
Q1 		$97K Buy
8,540
+4,900
+135% +$64.4K ﹤0.01% 1626
2021
Q4 		$55K Sell
3,640
-1,260
-26% -$22K ﹤0.01% 1711
2021
Q3 		$84K Hold
4,900
– – ﹤0.01% 1778
2021
Q2 		$105K Buy
4,900
+200
+4% +$3.58K ﹤0.01% 1671
2021
Q1 		$71K Hold
4,700
– – ﹤0.01% 1893
2020
Q4 		$62K Buy
+4,700
New +$56.6K ﹤0.01% 1930

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nisa Investment Advisors's VNDA Position: Q2 2026 in Review

Nisa Investment Advisors increased its Vanda Pharmaceuticals (VNDA) stake by 142% in Q2 2026, buying an estimated $1.31K and bringing the position to 341 shares worth $2.09K. The position accounts for ﹤0.01% of the portfolio, ranked #2747.

Nisa Investment Advisors first reported a position in VNDA in Q4 2020 and has held it in 18 quarters since. The position peaked at $105K in Q2 2021. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Nisa Investment Advisors held 341 shares of Vanda Pharmaceuticals worth $2.09K as of Q2 2026.
  • Nisa Investment Advisors bought 200 Vanda Pharmaceuticals shares in Q2 2026, an estimated $1.31K.
  • Vanda Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2747 holding.
  • Nisa Investment Advisors first reported a position in Vanda Pharmaceuticals in Q4 2020 and has held it in 18 quarters since.
  • Nisa Investment Advisors's Vanda Pharmaceuticals position peaked at $105K in Q2 2021.
  • 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.